S100A9 and acute myeloid leukemia: In conclusion, Seahorse data illustrate a difference in metabolic regulation of S100A9 in AML cells after genetic silencing (targeting intracellular S100A9) compared to pharmacological inhibition (targeting extracellular S100A9).